14:30 – 14:45 Opening Ceremony

14:45 – 15:45 Session 1: Aplastic Anemia & Neutropenia

Chair: E Hazan de Heraud (Peru)

• Are all aplastic anemias immune mediated?
  P Scheinberg (Brazil)
  
  
• Neutropenia
  E Papadaki (Greece)
  
  

15:45 – 16:15 Special lecture on Multiple Myeloma

Chair: D Fantl (Argentina)

• Future strategies for the treatment of Myeloma patients
  M Mateos (Spain)

16:15 – 17:15 Session 2: Thrombosis & coagulation

Chair: L Andino (Paraguay)

• Mechanisms of cancer-associated thrombosis
  C Dubois (France)
  
  
• Anticoagulation clinics - How far are we (in Argentina) from excellence?
  J Ceresetto (Argentina)

17:15 – 17:45 Coffee break

17:30 - 18:30 CSH General Assembly

18:30 – 19:45 SAH General assembly

09:00 – 10:00 Session 3: Leukemia

Chair: C Chiattone (Brazil)

• Bispecific antibodies in B-ALL
  R Foà (Italy)
  
  
• CAR-NK and CAR-iNKT cell therapy for CLL
  A Karadimitris (United Kingdom)

10:00 – 10:30 Coffee break

10:30 – 12:00 Session 4: Joint symposium on Hodgkin Lymphoma

Chairs: M Mateos (Spain) & G Stemmelin (Argentina)

• The alternative NF-kB pathway activity in refractory and relapsed Hodgkin Lymphoma
  S Ranuncolo (Argentina)
  
  
• Hodgkin Lymphoma ... far and beyond The Andes
  M Fuentes (Chile)
  
  
• Incorporating new approaches in advanced  and refractory HL: Peruvian reality
  E Fernandez (Peru)
  
  
• Relapsed/Refractory Hodgkin Lymphoma
  G dos Santos (Uruguay)
  
  
• Relapsed/Refractory Hodgkin's Lymphoma in Colombia. Local situation and current management strategies
  M Arevalo-Zambrano (Colombia)
  
  
• Hodgkin Lymphoma in Paraguay
  M Enciso (Paraguay)
  
  
• PET guided therapy in Hodgkin Lymphoma
  T Silveira (Brazil)

12:00 – 13:45 Lunch + Satellite Symposium

13:45 - 14:00 Break

14:00 - 15:30 Session 5: MDS / MPN

Chair: L Pilleux (Chile)

• Correlation between disease biology and clinical phenotype
  J Nangalia (United Kingdom)
  
  
• High risk MDS after HMA
  L Adès (France)
  
  
• Inheritability of MPN
  R Skoda (Switzerland)

15:30 - 16:30 Session 6: Red cell & iron disorders

Chair: L Diaz (Uruguay)

• The diagnostic potential of the iron-regulatory hormone hepcidin
  A Armitage (United Kingdom)
  
  
• Red cell membrane proteins
  L Bruce (United Kingdom)

16:00 - 16:30 Coffee break

16:30 – 18:30 Session 7: Non-Hodgkin Lymphoma

Chair: C Rosales (Colombia)

• Large B-cell lymphoma subtyping: a pathologist's viewpoint
  D de Jong (the Netherlands)
  
  
• Treatment of high risk follicular lymphoma
  W Jurczak (Poland)
  
  
• Treatment of Primary CNS lymphoma
  A Ferreri (Italy)
  
  
• Marginal zone lymphoma: differentiation among pathological challenging entities
  M Ponzoni (Italy)

18:30 – 19:00 Closing ceremony

21:00 SAH Closing Party